The European Union's pharmaceutical sector is in a constant state of progression. With exacting regulations, growing patient needs, and the swift pace of development, navigating this complex landscape requires a tactical approach. Pharmaceutical companies must adapt to such shifts by integrating innovative technologies, collaborating with key stake